Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

NCT03077685 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Interventions

DRUG: NanoPac®

Sponsor

NanOlogy, LLC

Collaborators

[object Object]